Tonix Pharmaceuticals

Tonix Pharmaceuticals is a commercial-stage biotech company building therapies and vaccines across CNS disorders, immunology, and infectious diseases. The pipeline spans FDA-approved TONMYA for fibromyalgia, candidates for acute stress disorder, Lyme disease prevention, organ transplant rejection, and acute migraine. That's a lot of regulated data moving through clinical, manufacturing, and commercial systems - each one a target.

For a security team, the threat model here is pharmaceutical-grade: protecting intellectual property around drug formulations and trial data, securing endpoints across a distributed research and commercial operation, and maintaining compliance with FDA 21 CFR Part 11, HIPAA, and GxP requirements. Clinical trial data, patient information, and proprietary research represent high-value assets that demand rigorous access controls, encryption, and audit trails. The attack surface includes everything from lab instrumentation to commercial sales platforms.

Tonix operates with a patient-centered, purpose-driven culture that emphasizes scientific rigor and integrity. Security roles here sit at the intersection of healthcare regulation and biotech innovation - defending systems that directly support drug development and commercialization. The work is concrete: hardening infrastructure that runs clinical operations, securing supply chain integrations, and ensuring the integrity of data pipelines that feed regulatory submissions.